COVID-19 RESPONSE - We are committed to supporting our scientific community during this pandemic. Learn more
WEBINAR
High-Throughput Screening
CiPA initiative and validation of high-throughput methods to characterize compound effects in human iPSC-derived cardiomyocytes
Use iPSC-derived cardiomyocytes for evaluation of compound effects and potential cardiotoxicity
Muthukrishnan Renganathan, PhD, Senior Scientist I Eurofins Discovery
Panida Lertkiatmongkol, PhD, Senior Scientist-Group Leader, Cell-based Screening I Eurofins Discovery
Oksana Sirenko, PhD, Senior Research Scientist I Molecular Devices
Carole Crittenden, Applications Scientist I Molecular Devices
View the webinar to:
- Hear the latest news on the CiPA initiative
- Learn how to evaluate compound induced effects on hiPSC-derived cardiomyocytes
- See the new features of the FLIPR Penta system and ScreenWorks® Peak Pro 2 software